Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ESPANA, Francisco")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 28

  • Page / 2
Export

Selection :

  • and

Polymorphisms in the endothelial protein C receptor gene and thrombophilia : Thrombophilia and anticoagulant pathwayMEDINA, Pilar; NAVARRO, Silvia; ESTELLES, Amparo et al.Thrombosis and haemostasis. 2007, Vol 98, Num 3, pp 564-569, issn 0340-6245, 6 p.Article

Haplotypes of the endothelial protein C receptor gene and Behçet's diseaseNAVARRO, Silvia; BONET, Elena; MEDINA, Pilar et al.Thrombosis research. 2012, Vol 129, Num 4, pp 459-464, issn 0049-3848, 6 p.Article

Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expressionRAMON, Luis A; GILABERT-ESTELLES, Juan; COSIN, Raul et al.Thrombosis research. 2008, Vol 122, Num 6, pp 854-860, issn 0049-3848, 7 p.Article

Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesionsZORIO, Esther; FALCO, Cristina; ARNAU, Miguel A et al.Haematologica (Roma). 2006, Vol 91, Num 4, pp 562-565, issn 0390-6078, 4 p.Article

The proportion of prostate-specific antigen (PSA) complexed to α1-Antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 μg/lMARTINEZ, Manuel; ESPANA, Francisco; ROYO, Montserrat et al.Clinical chemistry (Baltimore, Md.). 2002, Vol 48, Num 8, pp 1251-1256, issn 0009-9147Article

Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type I, and tissue metalloproteinase inhibitor type I gene expressions in primary breast cancerCASTELLO, Remedios; ESTELLES, Amparo; VAZQUEZ, Carlos et al.Clinical chemistry (Baltimore, Md.). 2002, Vol 48, Num 8, pp 1288-1295, issn 0009-9147, 8 p.Article

microRNAs expression in endometriosis and their relation to angiogenic factorsRAMON, Luis A; BRAZA-BOÏLS, Aitana; GILABERT-ESTELLES, Juan et al.Human reproduction (Oxford. Print). 2011, Vol 26, Num 5, pp 1082-1090, issn 0268-1161, 9 p.Article

Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosisROLDAN, Vanessa; ORDONEZ, Adriana; FONTCUBERTA, Jordi et al.Thrombosis and haemostasis. 2009, Vol 101, Num 3, pp 483-486, issn 0340-6245, 4 p.Article

Endothelial protein C receptor polymorphisms and risk of myocardial infarctionMEDINA, Pilar; NAVARRO, Silvia; ESPANA, Francisco et al.Haematologica (Roma). 2008, Vol 93, Num 9, pp 1358-1363, issn 0390-6078, 6 p.Article

Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphismSALK, Eva; VAYA, Amparo; ESPANA, Francisco et al.Thrombosis research. 2008, Vol 122, Num 3, pp 320-327, issn 0049-3848, 8 p.Article

Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancerCASTELLO, Remedios; LANDETE, Jose M; ESPANA, Francisco et al.Thrombosis research. 2007, Vol 120, Num 5, pp 753-762, issn 0049-3848, 10 p.Article

Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C systemZORIO, Esther; CASTELLO, Remedios; FALCO, Cristina et al.British journal of haematology. 2003, Vol 122, Num 6, pp 958-965, issn 0007-1048, 8 p.Article

Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levelsMEDINA, Pilar; BONET, Elena; NAVARRO, Silvia et al.Thrombosis and haemostasis. 2012, Vol 107, Num 3, pp 448-457, issn 0340-6245, 10 p.Article

Activated protein C levels in obesity and weight loss influenceSOLA, Eva; NAVARRO, Silvia; MEDINA, Pilar et al.Thrombosis research. 2009, Vol 123, Num 5, pp 697-700, issn 0049-3848, 4 p.Article

Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosisVAYA, Amparo; FALCO, Cristina; SIMO, Maria et al.Thrombosis and haemostasis. 2007, Vol 98, Num 3, pp 621-626, issn 0340-6245, 6 p.Article

Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V leidenMEDINA, Pilar; NAVARRO, Silvia; ESTELLES, Amparo et al.Thrombosis and haemostasis. 2005, Vol 94, Num 2, pp 389-394, issn 0340-6245, 6 p.Article

Flbrinolysis and lipoprotein(a) in women with coronary artery disease. influence of hormone replacement therapyFALCO, Cristina; TORMO, Gracia; ESTELLES, Amparo et al.Haematologica (Roma). 2001, Vol 86, Num 1, pp 92-98, issn 0390-6078Article

Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients : relationship with systemic inflammation and haemostatic activationMEZZANO, Diego; ESPANA, Francisco; QUIROGA, Teresa et al.British journal of haematology. 2001, Vol 113, Num 4, pp 905-910, issn 0007-1048Article

Plasma PAI-1 levels in obese children : Effect of weight loss and influence of PAI-1 promoter 4G/5G genotypeESTELLES, Amparo; DALMAU, Jaime; FALCO, Cristina et al.Thrombosis and haemostasis. 2001, Vol 86, Num 2, pp 647-652, issn 0340-6245Article

The endothelial cell protein C receptor: Its role in thrombosisNAVARRO, Silvia; BONET, Elena; ESTELLES, Amparo et al.Thrombosis research. 2011, Vol 128, Num 5, pp 410-416, issn 0049-3848, 7 p.Article

Heritability of plasma concentrations of activated protein C in a Spanish populationSORIA, José M; NAVARRO, Silvia; MEDINA, Pilar et al.Blood coagulation & fibrinolysis. 2009, Vol 20, Num 1, pp 17-21, issn 0957-5235, 5 p.Article

Fibrinolysis : The Key to New Pathogenetic MechanismsZORIO, Esther; GILABERT-ESTELLES, Juan; ESPANA, Francisco et al.Current medicinal chemistry. 2008, Vol 15, Num 9, pp 923-929, issn 0929-8673, 7 p.Article

Fibrinolytic inhibitor levels and polymorphisms in Behcet disease and their association with thrombosisRICART, José M; RAMON, Luis A; VAYA, Amparo et al.British journal of haematology. 2008, Vol 141, Num 5, pp 716-719, issn 0007-1048, 4 p.Article

Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutationNAVARRO, Silvia; MEDINA, Pilar; MIRA, Yolanda et al.Haematologica (Roma). 2008, Vol 93, Num 6, pp 885-891, issn 0390-6078, 7 p.Article

Activated protein C levels in Behçet's disease and risk of venous thrombosisNAVARRO, Silvia; RICART, José Maria; MEDINA, Pilar et al.British journal of haematology. 2004, Vol 126, Num 4, pp 550-556, issn 0007-1048, 7 p.Article

  • Page / 2